脑部放疗，上午比下午敏感许多！, d# E" f+ l4 T4 X) K" Y) r0 d0 o8 k% O
5 c O7 i2 r# u1 m
7 Q( R- o3 a" T8 g3 i% D
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
. ~; Y% f$ c wGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
8 t6 Q n0 ?9 }Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
% `" t7 n) ~1 Z" p1 v _ Y: P; sSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
- }) }4 g0 D8 p; @% q& ~. A {( u( O$ m6 V1 _; l
Abstract
" M$ _( W+ g, o6 yBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
0 E0 F2 O% w( T3 C
1 s3 P4 c ]7 D- wMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
; _( B5 V& g) [1 b" W, [! I! R, `; W1 L, K8 U1 T: R5 ~
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).3 a+ p& y( s5 j: h% ]& I' [
: p) ?/ S& A4 S" [9 f: R5 n" z$ t
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.) J% s W1 B( p
" z/ a' X0 k) F9 k, { |
. h/ |) B K6 }' A* t
显身卡
